Estados Unidos · Bolsa y Finanzas · The Motley Fool

Move Aside, Moderna: This mRNA Stock Is Sitting on a Cash Pile and a Deep Cancer Pipeline

Publicado por The Motley Fool · Estados Unidos hace 10 h

Wall Street is quite bullish on BioNTech. In fact, among the 20 analysts covering it, 13 rate the stock a strong buy, while the remainder rate it a hold. Their target prices imply…

Leer el artículo completo en The Motley Fool Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.fool.com)

Move Aside, Moderna: This mRNA Stock Is Sitting on a Cash Pile and a Deep Cancer Pipeline

También te puede interesar

Replit is no longer working with Anthropic, CEO says

My 2 friends and I had babies within 3 weeks of each other after 25 years of friendship. Our group chat became a lifeline.

Weak Links Start to Show in A.I. Borrowing

Alberta has the world’s fourth-largest oil reserves and sends 90% of its crude exports to the U.S. — It will vote on a first step to leaving Canada

Bulls vs. Bears: Is CoreWeave the canary in AI coalmine?

Crypto Super PAC Fairshake Pours Millions More Into Defeating Sherrod Brown

Move Aside, Moderna: This mRNA Stock Is Sitting on a Cash Pile and a Deep Cancer Pipeline

Compartir

También te puede interesar

Replit is no longer working with Anthropic, CEO says

My 2 friends and I had babies within 3 weeks of each other after 25 years of friendship. Our group chat became a lifeline.

Weak Links Start to Show in A.I. Borrowing

Alberta has the world’s fourth-largest oil reserves and sends 90% of its crude exports to the U.S. — It will vote on a first step to leaving Canada

Bulls vs. Bears: Is CoreWeave the canary in AI coalmine?

Crypto Super PAC Fairshake Pours Millions More Into Defeating Sherrod Brown